{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:19:12Z","timestamp":1788477552614,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58204-8","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:54:08Z","timestamp":1781693648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic properties of the fluid from the surgical ligation after breast-conserving therapy and intraoperative radiotherapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Agnieszka","family":"Gdowicz-K\u0142osok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Boguszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Skorupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Ciszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Turska-di","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Krze\u015bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"\u0141asut-Szyszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sok\u00f3l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Wydma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"58204_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21820","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21820 (2024).","journal-title":"J. Clin."},{"key":"58204_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA: A Cancer. J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"J. Clin."},{"key":"58204_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/BF02305771","volume":"3","author":"DR McCready","year":"1996","unstructured":"McCready, D. R. et al. Factors associated with local breast cancer recurrence after lumpectomy alone. Ann. Surg. Oncol. 3, 358\u2013366. https:\/\/doi.org\/10.1007\/BF02305771 (1996).","journal-title":"Ann. Surg. Oncol."},{"key":"58204_CR4","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker, M. et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates from the EORTC 10853 trial. J. Clin. Oncol. 31, 4054\u20134059. https:\/\/doi.org\/10.1200\/JCO.2013.49.5077 (2013).","journal-title":"J. Clin. Oncol."},{"key":"58204_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1023\/A:1011624629738","volume":"12","author":"JS Vaidya","year":"2001","unstructured":"Vaidya, J. S. et al. Targeted intra-operative radiotherapy (TARGIT): an innovative method for early breast cancer. Ann. Oncol. 12, 1075\u20131080. https:\/\/doi.org\/10.1023\/A:1011624629738 (2001).","journal-title":"Ann. Oncol."},{"key":"58204_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000521754","volume":"17","author":"MD Piroth","year":"2022","unstructured":"Piroth, M. D. et al. Long-term results of the TARGIT-A trial: More questions than answers. Breast Care 17, 81\u201384. https:\/\/doi.org\/10.1159\/000521754 (2022).","journal-title":"Breast Care"},{"key":"58204_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya, J. S. et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy: 5-year results of the TARGIT-A trial. The Lancet 383, 603\u2013613. https:\/\/doi.org\/10.1016\/S0140-6736(13)61950-9 (2014).","journal-title":"The Lancet"},{"key":"58204_CR8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","volume":"14","author":"U Veronesi","year":"2013","unstructured":"Veronesi, U. et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 14, 1269\u20131277. https:\/\/doi.org\/10.1016\/S1470-2045(13)70497-2 (2013).","journal-title":"Lancet Oncol."},{"key":"58204_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-07-4483","volume":"14","author":"B Belletti","year":"2008","unstructured":"Belletti, B. et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin. Cancer Res. 14, 1325\u20131332. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4483 (2008).","journal-title":"Clin. Cancer Res."},{"key":"58204_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.980513","volume":"12","author":"S Jeibouei","year":"2022","unstructured":"Jeibouei, S. et al. Biological and clinical review of IORT-induced wound fluid in breast cancer patients. Front. Oncol. 12, 980513. https:\/\/doi.org\/10.3389\/fonc.2022.980513 (2022).","journal-title":"Front. Oncol."},{"key":"58204_CR11","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.1158\/1078-0432.CCR-09-1149","volume":"15","author":"MA Troester","year":"2009","unstructured":"Troester, M. A. et al. Activation of host wound responses in breast cancer microenvironment. Clin. Cancer Res. 15, 7020\u20137028. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1149 (2009).","journal-title":"Clin. Cancer Res."},{"key":"58204_CR12","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3892\/ol.2016.5104","volume":"12","author":"K Zaleska","year":"2016","unstructured":"Zaleska, K., Suchorska, W. M., Przyby\u0142a, A. & Murawa, D. Effect of surgical wound fluids after IORT on the cancer stem cell phenotype in human breast cancer cell lines. Oncol. Lett. 12, 3707\u20133714. https:\/\/doi.org\/10.3892\/ol.2016.5104 (2016).","journal-title":"Oncol. Lett."},{"key":"58204_CR13","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3892\/ol.2017.6628","volume":"14","author":"K Zaleska","year":"2017","unstructured":"Zaleska, K. et al. Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines; effect partially abrogated by IORT. Oncol. Lett. 14, 4029\u20134036. https:\/\/doi.org\/10.3892\/ol.2017.6628 (2017).","journal-title":"Oncol. Lett."},{"key":"58204_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5603\/GP.a2018.0030","volume":"89","author":"KI Kulcenty","year":"2018","unstructured":"Kulcenty, K. I., Piotrowski, I., Zaleska, K., Murawa, D. & Suchorska, W. M. Wound fluids collected after IORT activate the extrinsic apoptotic pathway in MCF7 cells. Ginekol. Pol. 89, 175\u2013182. https:\/\/doi.org\/10.5603\/GP.a2018.0030 (2018).","journal-title":"Ginekol. Pol."},{"key":"58204_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/nbm.1232","volume":"21","author":"L Bala","year":"2008","unstructured":"Bala, L. et al. 1H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison with conventional methods. J. Magn. Reson. Biomed. 21, 606\u2013614. https:\/\/doi.org\/10.1002\/nbm.1232 (2008).","journal-title":"J. Magn. Reson. Biomed."},{"key":"58204_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpba.2017.01.018","volume":"137","author":"A Junka","year":"2017","unstructured":"Junka, A. et al. Metabolic profiles of exudates from chronic leg ulcerations. J. Pharm. Biomed. Anal. 137, 13\u201322. https:\/\/doi.org\/10.1016\/j.jpba.2017.01.018 (2017).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"58204_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12885-021-08137-4","volume":"21","author":"\u0141 Boguszewicz","year":"2021","unstructured":"Boguszewicz, \u0141 et al. Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics. BMC Cancer 21, 410. https:\/\/doi.org\/10.1186\/s12885-021-08137-4 (2021).","journal-title":"BMC Cancer"},{"key":"58204_CR18","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.3390\/ijms25147555","volume":"25","author":"\u0141 Boguszewicz","year":"2024","unstructured":"Boguszewicz, \u0141 et al. NMR-based metabolomics of blood serum in predicting response to induction chemotherapy in head and neck cancer. Int. J. Mol. Sci. 25, 7555. https:\/\/doi.org\/10.3390\/ijms25147555 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"58204_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3927","volume":"32","author":"GF Giske\u00f8deg\u00e5rd","year":"2018","unstructured":"Giske\u00f8deg\u00e5rd, G. F., Madssen, T. S., Euceda, L. R. & Bathen, T. F. NMR-based metabolomics of biofluids in cancer. NMR Biomed. 32, e3927. https:\/\/doi.org\/10.1002\/nbm.3927 (2018).","journal-title":"NMR Biomed."},{"key":"58204_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/metabo9050102","volume":"9","author":"C Silva","year":"2019","unstructured":"Silva, C., Perestrelo, R., Silva, P., Tom\u00e1s, H. & C\u00e2mara, J. S. Breast cancer metabolomics: from analytical platforms to multivariate data analysis. Metabolites 9, 102. https:\/\/doi.org\/10.3390\/metabo9050102 (2019).","journal-title":"Metabolites"},{"key":"58204_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161038","volume":"11","author":"EY Chae","year":"2016","unstructured":"Chae, E. Y. et al. The role of high-resolution magic angle spinning 1H NMR spectroscopy for predicting the invasive component in ductal carcinoma in situ. PLoS ONE 11, e0161038. https:\/\/doi.org\/10.1371\/journal.pone.0161038 (2016).","journal-title":"PLoS ONE"},{"key":"58204_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/metabo9020019","volume":"9","author":"M Gogiashvili","year":"2019","unstructured":"Gogiashvili, M. et al. HR-MAS NMR based quantitative metabolomics in breast cancer. Metabolites 9, 19. https:\/\/doi.org\/10.3390\/metabo9020019 (2019).","journal-title":"Metabolites"},{"key":"58204_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ab.2015.07.015","volume":"488","author":"RM Maria","year":"2015","unstructured":"Maria, R. M. et al. Characterization of metabolic profile of intact breast cells by HR-MAS NMR. Anal. Biochem. 488, 14\u201318. https:\/\/doi.org\/10.1016\/j.ab.2015.07.015 (2015).","journal-title":"Anal. Biochem."},{"key":"58204_CR24","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1021\/acs.biochem.7b00088","volume":"56","author":"RM Maria","year":"2017","unstructured":"Maria, R. M., Altei, W. F., Selistre-de-Araujo, H. S. & Colnago, L. A. Effects of doxorubicin, cisplatin and tamoxifen on metabolic profile of MCF-7 cells by HR-MAS NMR. Biochemistry 56, 2219\u20132224. https:\/\/doi.org\/10.1021\/acs.biochem.7b00088 (2017).","journal-title":"Biochemistry"},{"key":"58204_CR25","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/cancers15041283","volume":"15","author":"A Skorupa","year":"2023","unstructured":"Skorupa, A. et al. The relationship between histological composition and metabolic profile in breast tumors and peritumoral tissue determined with 1H HR-MAS NMR spectroscopy. Cancers 15, 1283. https:\/\/doi.org\/10.3390\/cancers15041283 (2023).","journal-title":"Cancers"},{"key":"58204_CR26","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.3390\/ijms22094687","volume":"22","author":"A Vignoli","year":"2021","unstructured":"Vignoli, A. et al. Precision oncology via NMR-based metabolomics: a review on breast cancer. Int. J. Mol. Sci. 22, 4687. https:\/\/doi.org\/10.3390\/ijms22094687 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"58204_CR27","first-page":"320","volume":"55","author":"J Wydma\u0144ski","year":"2005","unstructured":"Wydma\u0144ski, J. et al. A new method of targeted intraoperative radiotherapy using the orthovoltage photon radiosurgery system. Nowotwory J. Oncol. 55, 320 (2005).","journal-title":"Nowotwory J. Oncol."},{"issue":"1","key":"58204_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/ijms25010188.PMID:38203359;PMCID:PMC10779362","volume":"25","author":"\u0141 Boguszewicz","year":"2023","unstructured":"Boguszewicz, \u0141 et al. Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Int J Mol Sci. 25(1), 188. https:\/\/doi.org\/10.3390\/ijms25010188.PMID:38203359;PMCID:PMC10779362 (2023).","journal-title":"Int J Mol Sci."},{"key":"58204_CR29","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2, 2692\u20132703. https:\/\/doi.org\/10.1038\/nprot.2007.376 (2007).","journal-title":"Nat. Protoc."},{"issue":"7","key":"58204_CR30","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/cancers15072127.PMID:37046788;PMCID:PMC10093525","volume":"15","author":"E Derveaux","year":"2023","unstructured":"Derveaux, E. et al. NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung Cancer. Cancers 15(7), 2127. https:\/\/doi.org\/10.3390\/cancers15072127.PMID:37046788;PMCID:PMC10093525 (2023).","journal-title":"Cancers"},{"issue":"2","key":"58204_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyx271","volume":"47","author":"L L\u00e9cuyer","year":"2018","unstructured":"L\u00e9cuyer, L. et al. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer. Int J Epidemiol. 47(2), 484\u2013494. https:\/\/doi.org\/10.1093\/ije\/dyx271 (2018).","journal-title":"Int J Epidemiol."},{"issue":"1","key":"58204_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2013.09.011","volume":"343","author":"E Jobard","year":"2014","unstructured":"Jobard, E. et al. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer. Cancer Lett. 343(1), 33\u201341. https:\/\/doi.org\/10.1016\/j.canlet.2013.09.011 (2014).","journal-title":"Cancer Lett."},{"issue":"10","key":"58204_CR33","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.3390\/ijms23105324.PMID:35628139;PMCID:PMC9141543","volume":"23","author":"S Joshi","year":"2022","unstructured":"Joshi, S. et al. Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. Int J Mol Sci. 23(10), 5324. https:\/\/doi.org\/10.3390\/ijms23105324.PMID:35628139;PMCID:PMC9141543 (2022).","journal-title":"Int J Mol Sci."},{"key":"58204_CR34","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3390\/cancers17111751","volume":"17","author":"K Xu","year":"2025","unstructured":"Xu, K., Shah, P., Makhanasa, D. & Khan, M. W. Unveiling the Maze: Branched-Chain Amino Acids Fueling the Dynamics of Cancer Metabolism and Progression. Cancers 17, 1751. https:\/\/doi.org\/10.3390\/cancers17111751 (2025).","journal-title":"Cancers"},{"issue":"15","key":"58204_CR35","doi-asserted-by":"publisher","first-page":"1516785","DOI":"10.3389\/fonc.2025.1516785.PMID:39968078;PMCID:PMC11832377","volume":"4","author":"K Al-Malsi","year":"2025","unstructured":"Al-Malsi, K. et al. The role of lactylation in tumor growth and cancer progression. Front Oncol. 4(15), 1516785. https:\/\/doi.org\/10.3389\/fonc.2025.1516785.PMID:39968078;PMCID:PMC11832377 (2025).","journal-title":"Front Oncol."},{"key":"58204_CR36","doi-asserted-by":"publisher","unstructured":"Liu, Y., Li, J., Cao, Y. & Lv, M. Rewired glycolysis by DTL accelerates oncometabolite l-lactate generation to promote breast cancer progression. Front. Oncol. 15, 1583752. https:\/\/doi.org\/10.3389\/fonc.2025.1583752 (2025).","DOI":"10.3389\/fonc.2025.1583752"},{"issue":"1","key":"58204_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40170-022-00289-6.PMID:35978348;PMCID:PMC9382832","volume":"10","author":"R An","year":"2022","unstructured":"An, R. et al. Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer. Cancer Metab. 10(1), 13. https:\/\/doi.org\/10.1186\/s40170-022-00289-6.PMID:35978348;PMCID:PMC9382832 (2022).","journal-title":"Cancer Metab."},{"issue":"6","key":"58204_CR38","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-16-1153","volume":"23","author":"CD Hart","year":"2017","unstructured":"Hart, C. D. et al. Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population. Clin Cancer Res. 23(6), 1422\u20131431. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1153 (2017).","journal-title":"Clin Cancer Res."},{"issue":"7","key":"58204_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/metabo15070428","volume":"15","author":"R Perestrelo","year":"2025","unstructured":"Perestrelo, R. & Lu\u00eds, C. Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine. Metabolites 15(7), 428. https:\/\/doi.org\/10.3390\/metabo15070428 (2025).","journal-title":"Metabolites"},{"key":"58204_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/cells8020181","volume":"8","author":"R Agresti","year":"2019","unstructured":"Agresti, R. et al. Wound Healing Fluid Reflects the Inflammatory Nature and Aggressiveness of Breast Tumors. Cells 8, 181. https:\/\/doi.org\/10.3390\/cells8020181 (2019).","journal-title":"Cells"},{"issue":"9","key":"58204_CR41","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/cancers13092140","volume":"13","author":"A Wuhrer","year":"2021","unstructured":"Wuhrer, A. et al. Wound Fluid from Breast Cancer Patients Undergoing Intraoperative Radiotherapy Exhibits an Altered Cytokine Profile and Impairs Mesenchymal Stromal Cell Function. Cancers (Basel). 13(9), 2140. https:\/\/doi.org\/10.3390\/cancers13092140 (2021).","journal-title":"Cancers (Basel)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58204-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:48:20Z","timestamp":1788475700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58204-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58204"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58204-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the use of samples from breast cancer patients CONFIRMS that all experiments were conducted in accordance with the relevant guidelines and regulations. The authors confirm that all methods were performed in accordance with the relevant guidelines and regulations. The authors confirm that all experimental protocols were approved by the Bioethics Committee. The study was approved by the Bioethics Committee of the Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Gliwice Branch (No. KB\/430\u2009\u2212\u200929\/23, approved on March 16, 2023).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27702"}}